Thanks! You've successfully subscribed to the BONEZONE®/OMTEC® Monthly eNewsletter!

Please take a moment to tell us more about yourself and help us keep unwanted emails out of your inbox.

Choose one or more mailing lists:
BONEZONE/OMTEC Monthly eNewsletter
OMTEC Conference Updates
Advertising/Sponsorship Opportunities
Exhibiting Opportunities
* Indicates a required field.

 Sponsored by


KEYNOTE | State and Future of the Orthopedic Industry:
Device Executive Perspective

When: Wednesday, June 12 | 7:30 am - 9:00 am (Breakfast served at 7:30 am, Opening Remarks at 7:45 am, Keynote at 8:00 am)
Where: Room 51
All OMTEC participants are welcome to attend.

Read the recap on BONEZONE®. 

keynote wed


How will orthopedic care be delivered in the future?
Presently, surgeries are migrating to outpatient settings, hospitals and payors are emphasizing episode of care, digital health tools are gaining ground and technology companies are building a place for themselves at the healthcare table. 
Orthopedic manufacturers must respond to these shifts to survive and thrive.

All departments, especially product development, supply chain, regulatory and sales, have a role to play in the future of care delivery. This OMTEC Keynote panel brings together a diversified group of executives who are leading companies of various sizes and market segments. Themes that they'll discuss include the role of ASCs, data and personalized medicine to drive technology innovation and manufacturing and supply chain efficiencies.


Mike Mogul is President and Managing Director of private equity firm HealthpointCapital. Previously, he was President, Chief Executive Officer and Director of DJO Global. Prior to joining DJO, Mr. Mogul served as Group President, Orthopaedics for Stryker, managing the company's global orthopedic businesses which represented approximately $3 billion in revenue. Additionally, in his 22 years in the musculoskeletal space at Stryker, Mr. Mogul served as Managing Director of all of Stryker’s divisional segments in Austria, Germany and Switzerland. He received a Bachelor of Science degree from the University of Colorado and has attended the Advanced Management Program at the Harvard Business School.


Rob Ball is the Chairman and Chief Executive Officer of Genesis Innovation Group, where he manages Medical Device Engineering and Development. He has spent more than a decade bringing medical device technologies to market, including proprietary orthopedic materials. He served at Tornier as Global Vice President, Research and Development, during which time the company grew from approximately $70MM to $300MM in annual revenues through organic growth of new products. Prior roles include Vice President of Marketing and Product Development at Kinetikos Medical and R&D Engineer at DePuy Orthopaedics. Mr. Ball holds more than 30 issued or pending patents.

Vernon Hartdegen is Co-Founder, President and CEO of CrossRoads Extremity Systems, a foot and ankle device company. Prior to CrossRoads, Mr. Hartdegen served in R&D, product development and operations roles for more than 20 years, including Vice President Research & Development at Biomimedica, Senior Director of Product Development at Sonoma Orthopedics, Senior Director Product Development at Wright Medical and a Development Engineer at Smith & Nephew. He holds a Bachelor of Science in Biomedical Engineering from Louisiana Tech University and a Master’s in Biomechanical Engineering from The University of Tennessee Health Science Center.

Andy McLeod is President of Corin USA, a wholly-owned division of the U.K.-based medical device company Corin Group. Previously, Mr. McLeod served as Chief Commercial Officer of Bodycad, a developer of personalized knee implants. He has over 25 years of experience across multiple organizations, including 22+ years with Johnson & Johnson. At Bodycad, he led the company from initial concept to full commercialization. Prior to that, he served as President and Chief of Operations for Medacta USA, a manufacturer of devices for joint reconstruction, spine and sports medicine applications.

Padraic Obma, M.D., is Founder and Chief Executive Officer of Strive Orthopedics, a platform for remote orthopedic care that utilizes software, data, sensors and algorithms to assess injuries and pain and provide recommendations to improve musculoskeletal health. Dr. Obma specializes in robotic-assisted total and partial joint replacement, as well as arthroscopic surgery of the shoulder, elbow, hip, knee and ankle. Fellowship-trained in sports medicine, he has filed several patents based on medical innovations he devised, including the invention of a new shoulder procedure to repair torn rotator cuff tendons. He received his doctorate from the Medical College of Wisconsin and practices at the Orthopedic Clinic of Appleton.